Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics
Authors
Keywords
Trastuzumab, Liposomal Doxorubicin, Gemtuzumab Ozogamicin, Interstitial Fluid Pressure, Brentuximab Vedotin
Journal
DRUGS
Volume 75, Issue 14, Pages 1601-1611
Publisher
Springer Nature
Online
2015-08-31
DOI
10.1007/s40265-015-0453-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radionuclides in drug development
- (2015) Philipp Uhl et al. DRUG DISCOVERY TODAY
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
- (2015) Andreas Wicki et al. JOURNAL OF CONTROLLED RELEASE
- A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
- (2014) A. Awada et al. ANNALS OF ONCOLOGY
- A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
- (2014) Hee Kyung Ahn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vaccination therapy for non-small-cell lung cancer
- (2014) Kristof Cuppens et al. CURRENT OPINION IN ONCOLOGY
- Radionuclide imaging of drug delivery for patient selection in targeted therapy
- (2014) Sandra Heskamp et al. Expert Opinion on Drug Delivery
- Pharmacokinetic and Pharmacodynamic Properties of Calaspargase PegolEscherichia coliL-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4
- (2014) Anne L. Angiolillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive, Locally Advanced, or Metastatic Breast Cancer
- (2014) Kathy D. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
- (2014) Neil Desai et al. Translational Oncology
- A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
- (2013) A H Ko et al. BRITISH JOURNAL OF CANCER
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Trastuzumab Emtansine: First Global Approval
- (2013) Anita Ballantyne et al. DRUGS
- SPARC independent drug delivery and antitumour effects ofnab-paclitaxel in genetically engineered mice
- (2013) Albrecht Neesse et al. GUT
- Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
- (2013) Ahmad Awada et al. LANCET ONCOLOGY
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation
- (2013) Anil Kumar et al. Nanoscale
- Monoclonal antibody-based therapies in cancer: Advances and challenges
- (2013) Puja Sapra et al. PHARMACOLOGY & THERAPEUTICS
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
- (2012) Jeffrey A. Silverman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
- (2012) W. C. Zamboni et al. CLINICAL CANCER RESEARCH
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- Neoadjuvant Paclitaxel Poliglumex, Cisplatin, and Radiation for Esophageal Cancer
- (2011) Thomas Dipetrillo et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
- (2011) Paola Milla et al. CURRENT DRUG METABOLISM
- Polymer–drug conjugates as nano-sized medicines
- (2011) Fabiana Canal et al. CURRENT OPINION IN BIOTECHNOLOGY
- Liposomal drug formulations in cancer therapy: 15 years along the road
- (2011) Marije Slingerland et al. DRUG DISCOVERY TODAY
- Pegylated Liposomal Doxorubicin
- (2011) Sean T. Duggan et al. DRUGS
- Impact of albumin on drug delivery — New applications on the horizon
- (2011) Bakheet Elsadek et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine(s) under the Microscope
- (2011) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
- (2011) Yutaka Yamamoto et al. OncoTargets and Therapy
- Development of cytarabine prodrugs and delivery systems for leukemia treatment
- (2010) Bhupender S Chhikara et al. Expert Opinion on Drug Delivery
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
- (2010) Klaus Maier-Hauff et al. JOURNAL OF NEURO-ONCOLOGY
- Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
- (2010) Xiaowei Dong et al. Nanomedicine
- Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
- (2010) Chris Oerlemans et al. PHARMACEUTICAL RESEARCH
- Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid Tumors
- (2010) Gerben A. Koning et al. PHARMACEUTICAL RESEARCH
- Heterogeneity of the Tumor Vasculature
- (2010) Janice Nagy et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Mifamurtide
- (2010) James E. Frampton PEDIATRIC DRUGS
- PEG conjugates in clinical development or use as anticancer agents: An overview
- (2009) Gianfranco Pasut et al. ADVANCED DRUG DELIVERY REVIEWS
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
- Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2009) Corey J. Langer et al. Journal of Thoracic Oncology
- Protein nanoparticles as drug carriers in clinical medicine
- (2008) Michael J. Hawkins et al. ADVANCED DRUG DELIVERY REVIEWS
- Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
- (2008) Neil P. Desai et al. ANTI-CANCER DRUGS
- Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
- (2008) L Paz-Ares et al. BRITISH JOURNAL OF CANCER
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Cytotoxicity of Nanoparticles
- (2007) Nastassja Lewinski et al. Small
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now